Beta Biotech Medicine Profile
Key Indicators
- Authorised Capital ₹ 0.11 M
as on 02-12-2024
- Paid Up Capital ₹ 0.10 M
as on 02-12-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -778.10%
(FY 2020)
- Ebitda -778.10%
(FY 2020)
- Net Worth -1.21%
(FY 2020)
- Total Assets -9.27%
(FY 2020)
About Beta Biotech Medicine
The Corporate was formerly known as Swastika Pharmaceuticals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.11 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajnish Dixit and Satish Sharma serve as directors at the Company.
- CIN/LLPIN
U24232PB2000PTC024041
- Company No.
024041
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2000
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Beta Biotech Medicine?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnish Dixit  | Managing Director | 06-Nov-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satish Sharma | Director | 06-Nov-2000 | Current |
Financial Performance of Beta Biotech Medicine.
Beta Biotech Medicine Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 778.1% decrease in profit. The company's net worth dipped by a decrease of 1.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Beta Biotech Medicine?
In 2020, Beta Biotech Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Beta Biotech Medicine?
Unlock and access historical data on people associated with Beta Biotech Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Beta Biotech Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beta Biotech Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
